|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
EyePoint Pharmaceuticals, Inc. - Common Stock [EYPT]
$1.69 0.09 (5.06%)
Market Cap 200 Million
EyePoint Pharmaceuticals Inc is a US-based specialty pharmaceutical company which is engaged in developing sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. The company has developed three sustained-release products for the treatment of back-of-the-eye diseases. The lead product candidate is Durasert which is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye for three years from a single injection. The company's development program is focused primarily on utilizing two core technology platforms to deliver drugs and biologics to treat chronic diseases.
EPS -0.12 P/E Ratio 0.00
Previous Earnings Thu, Mar 14, 2019
Pay Date --
This list of trending stocks may change throughout the trading day.